Skip to main content
Ingredients/Compound/(25)-D-Spirosta-3,5-Diene

(25)-D-Spirosta-3,5-Diene.

Strength pending.The research strength is not set yet.

It's a steroid-shaped plant compound formed when fenugreek or wild yam extract is boiled with acid. Having lost its sugar-attachment point, it behaves as a neutral fat-soluble molecule.

DSCompound
(25)-D-Spirosta-3,5-DieneIngredientMD
Category
Compound

What (25)-D-Spirosta-3,5-Diene is, and what it does.

Does it work
It suits anyone who wants to understand what a fenugreek or wild yam extract actually contains. Human enzymes can't open its side chain, so it doesn't become a hormone in the body.
How much to take
No daily figure is on record. It turns up as a fraction of a fenugreek or wild yam extract rather than as something dosed alone, so the extract amount is what applies.
Time to feel it
Nobody has measured a time to effect in people. There is one record for it in the published literature, and it isn't a human dosing study.
The first dose
Day one is quiet. Because it's fully lipophilic, taking the extract with a meal containing fat is what decides how much of it gets absorbed at all.
With regular use
Nobody has measured what weeks of intake do with this compound on its own. What has been studied is the whole extract it arrives inside.
How well tolerated
No human tolerance record exists for the isolated compound. Fenugreek extracts are generally well tolerated, and anyone pregnant or on glucose-lowering medication should ask a clinician.
How it feels
No sensation is tied to it. It shows up as a peak on an extract's chromatogram, which is how a manufacturer reads how its processing ran.
The overlooked benefit
It works as a process fingerprint. Finding it tells you the extract was acid-hydrolysed rather than gently prepared, which is real information about how a product was made.

The proof, claim by claim.

These words describe the research, not the molecule's worth. Research strength is how much work stands behind one claim, and it is never a product score.

  • recognised intermediate in semisynthetic steroid manufactureNarrative review
  • marker of acid hydrolysis in sapogenin-containing plant extractsNarrative review
  • absence of a human enzymatic route from plant spirostanes to hormonesNarrative review
PubMedCochraneClinicalTrials.govNIH ODSSUPP.AILabs test. IngredientMD verifies.PubMedCochraneClinicalTrials.govNIH ODSSUPP.AILabs test. IngredientMD verifies.
Pairs well with4 on file

Why these belong in the same formula. Each row says what the basis is, from settled biochemistry through to a trial that measured the pair.

(25)-D-Spirosta-3,5-Diene + FenugreekBotanical co-occurrence and shared extraction chemistry.

Fenugreek seed is a commercial source of steroidal sapogenins, and acid hydrolysis of its saponins generates diene by-products including this one. Supplements standardised to fenugreek sapogenins can therefore contain the diene as a processing artefact. The amount depends entirely on how aggressive the hydrolysis step was.

(25)-D-Spirosta-3,5-Diene + MCT oilEstablished physical chemistry of lipophilic steroidal compounds.

The compound is a non-polar steroid skeleton with no ionisable groups, so it dissolves in lipid and not in water. A medium chain triglyceride carrier keeps it in solution in a softgel and gives it a lipid phase to partition into in the gut. This is a delivery relationship rather than a biological one.

(25)-D-Spirosta-3,5-Diene + Sunflower lecithinFormulation practice for poorly water soluble steroid-type actives.

Phospholipid emulsifiers help disperse lipophilic sapogenin-derived material into mixed micelles. This is standard practice for any steroid skeleton with negligible aqueous solubility. It changes dispersion, and dispersion is not the same thing as a measured change in blood levels.

(25)-D-Spirosta-3,5-Diene + Vitamin EEstablished oxidation chemistry of dienes.

A conjugated 3,5-diene in a steroid ring is an oxidation-prone motif. Tocopherol is the usual lipid-phase antioxidant added to protect such structures in an oil fill during shelf life. The benefit is to the raw material in the capsule, not to the person taking it.

Who should be cautious

Nothing specific on file for (25)-D-Spirosta-3,5-Diene. Match the label to the daily amount above, and tell your doctor what you take.

Not medical advice. Show the label to your pharmacist.

What (25)-D-Spirosta-3,5-Diene actually does.

Established

This molecule is a steroid-like plant compound with a side ring structure and a double bond pattern, formed when a plant sapogenin loses a hydroxyl group under acid or heat.

Established

Losing that hydroxyl group removes the spot where sugars would normally attach, so this form can't exist as a saponin and instead behaves as a fully fat-soluble neutral steroid.

Established

In steroid manufacturing, compounds like this are known stepping stones on the way from plant compounds to other steroid types, which is the main reason it's studied at all.

Established

The body's own steroid-making pathway doesn't open up this kind of side-ring structure, so the common claim that plant steroids like this convert into human hormones after you eat them isn't backed by any known enzyme pathway.

Grown, 5 steps on record

Where (25)-D-Spirosta-3,5-Diene comes from.

It comes from fenugreek seed or wild yam. When makers boil the plant extract with acid to strip off the sugars, part of the resulting compound loses a water molecule and turns into this one. So it is partly a plant compound and partly a by-product of how the extract was made.

Made from a plant. What ends up in the capsule tracks the harvest, so batch testing and a stated marker matter more here than with a made molecule.

Starts as
Steroidal saponin bearing plant material

Fenugreek seed, wild yam rhizome or a related Dioscorea species, all of which accumulate spirostanol saponins.

Extracted by
Solvent extraction of crude saponins

Aqueous alcohol pulls the glycosylated saponins out of the milled plant material.

Converted by
Acid hydrolysis

Heating with acid cleaves the sugar chain to release the sapogenin, and the same conditions eliminate the 3-hydroxyl to form the 3,5-diene.

Purified by
Crystallisation or chromatography

The diene is separated from diosgenin and other sapogenins on the basis of polarity.

Ends up as
Oil dispersion or micronised powder

Blended into a lipid carrier for softgels, or milled for dry capsules.

The forms it comes in.

Spirosta-3,5-diene, unesterifiedNeutral lipophilic spirostane with a conjugated 3,5-diene. No acidic or basic centre, so no salt is possible.Fits Oil-based softgels and lipid dispersions where a fat carrier is already present.Trade-off Negligible water solubility means intake without dietary fat leaves most of the dose undispersed.
Fenugreek or wild yam extract containing the dieneA mixture in which the diene sits alongside diosgenin, other sapogenins and residual plant lipids from the hydrolysis step.Fits Botanical-facing products where the label declares a plant extract rather than an isolated compound.Trade-off The proportion of diene varies batch to batch with hydrolysis conditions, so a fixed intake is hard to state.Active and formulation aid
Micronised crystalline materialReduced particle size increases surface area available to bile salt micelles.Fits Dry capsule and tablet formats where an oil fill is not an option.Trade-off Surface area helps dissolution but does nothing about the underlying lipophilicity, so a fatty meal still matters.

FDA Disclaimer: These statements have not been evaluated by the Food and Drug Administration. This information is for educational purposes only and is not intended to diagnose, treat, cure, or prevent any disease. Consult your healthcare provider before starting any supplement regimen.